MUFG Securities EMEA’s Integra LifeSciences IART Stock Holding History

MUFG Securities EMEA’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-96,100	Closed	-$6.44M	–	178
2021 Q4	$6.44M	Buy	+96,100	New	+$6.5M	0.1%	78
2021 Q3	–	Sell	-70,000	Closed	-$4.78M	–	315
2021 Q2	$4.78M	Buy	70,000 +48,460	+225%	+$3.43M	0.05%	170
2021 Q1	$1.49M	Sell	21,540 -72,460	-77%	-$4.91M	0.01%	282
2020 Q4	$6.1M	Buy	94,000 +44,000	+88%	+$2.37M	0.05%	193
2020 Q3	$2.36M	Sell	50,000 -25,000	-33%	-$1.19M	0.02%	262
2020 Q2	$3.52M	Buy	+75,000	New	+$3.69M	0.03%	247

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

MUFG Securities EMEA's IART Position: Q1 2022 in Review

MUFG Securities EMEA sold out of Integra LifeSciences (IART) in Q1 2022, closing a stake of 96,100 shares — an estimated $6.44M sold.

MUFG Securities EMEA first reported a position in IART in Q2 2020 and held it in 6 quarters. The position peaked at $6.44M in Q4 2021. 278 funds tracked by Wall St. Rank hold IART as of Q1 2022.

MUFG Securities EMEA reported no remaining Integra LifeSciences position as of Q1 2022 after selling out during the quarter.
MUFG Securities EMEA sold 96,100 Integra LifeSciences shares in Q1 2022, an estimated $6.44M.
MUFG Securities EMEA first reported a position in Integra LifeSciences in Q2 2020 and held it in 6 quarters.
MUFG Securities EMEA's Integra LifeSciences position peaked at $6.44M in Q4 2021.
278 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2022.

Based on MUFG Securities EMEA's 13F filing for Q1 2022, filed 10 May 2022.